A pharma company near its ATH looks interesting as fundamentals seem good. WIth a market cap of less than 5000 crores, and sales to market cap of 3x... the runway is long.
It has broken out of a 6 week consolidation zone and demand seems good though RSI is not yet supporting. There is overhead supply as it approaches all time high. So keep this in the watchlist.